Comparative Effectiveness

Subscribe to Comparative Effectiveness

The HHS Office of the Assistant Secretary for Planning and Evaluation has published a notice seeking comments on the development of a national inventory of comparative effectiveness research (CER) and CER-related information. Comments should focus on appropriate resources and approaches for developing the CER Inventory, including sources of CER, ways to encourage participation, categorizing content,…

The Government Accountability Office (GAO) is seeking nominations for the ACA’s Patient Centered Outcomes Research Institute Governing Board, which is charged with identifying national priorities for comparative effectiveness research.  Likewise, the GAO is seeking nominations for the National Health Care Workforce Commission, also established by the ACA.  Nominations for both panels are due…

The Agency for Healthcare Research and Quality (AHRQ) Effective Health Care Program has issued two reports that examine when AHRQ should update comparative effectiveness reviews (CERs). The first document is a draft research review on “Updating Comparative Effectiveness Reviews”. This guidance sets forth a framework for identifying new evidence or evidence not considered in a…

The American Recovery and Reinvestment Act (ARRA) included a major expansion of federal efforts to compare the effectiveness of different medical treatments, including more than $1 billion in funding for comparative effectiveness research (CER). Two federal panels recently released reports on CER priorities under the ARRA. First, the Federal Coordinating Council for Comparative Effectiveness Research…

On June 10, 2009, the Federal Coordinating Council for Comparative Effectiveness Research is holding a meeting in Washington D.C. to hear public comments on the Council’s efforts to coordinate research and guide investments in comparative effectiveness research funded by the American Recovery and Reinvestment Act of 2009 (ARRA). The Council is soliciting comments on:

  • What

…

On May 26, 2009, the Federal Comparative Effectiveness Research Coordination Council announced that it is seeking comment on its draft definition of comparative effectiveness research and its draft prioritization criteria for comparative effectiveness research and investments. With regard to prioritization, the Council proposes to use the following criteria for determining “scientifically meritorious research and investments” …

HHS has released a series of American Recovery and Reinvestment Act (ARRA) Implementation Plans, detailing how the department is addressing key aspects of the legislation. Specifically, the plans highlight the following areas: Improving and Preserving Health Care (including increases in the Medicaid Federal Medical Assistance Percentage); Accelerating the Adoption of Health Information Technology; Strengthening Scientific…

On April 14, 2009, the Federal Coordinating Council for Comparative Effectiveness Research will hold a public listening session regarding comparative effectiveness research and the Coordinating Council’s activities. By way of background, the Council was authorized by the ARRA as part of a major expansion of federal efforts to compare the effectiveness of different medical treatments,…

On March 19, 2009, HHS announced the members of the Federal Coordinating Council for Comparative Effectiveness Research. The Council was authorized by the American Recovery and Reinvestment Act (ARRA) as part of a major expansion of federal efforts to compare the effectiveness of different medical treatments, including both infrastructure changes and an infusion of $1…

The Senate HELP Committee is holding a January 28, 2016 hearing on “Generic Drug User Fee Amendments: Accelerating Patient Access to Generic Drugs.”  Separately, on February 4, the House Committee on Oversight and Government Reform has scheduled a hearing on “Developments in the Prescription Drug Market: Oversight.”  Other recent Congressional health policy hearings…

On February 17, 2009, President Obama signed into law H.R. 1, the American Recovery and Reinvestment Act (the “ARRA”). The sweeping $790 billion economic stimulus package includes a number of health care policy provisions. Reed Smith’s Health Care Memorandum summarizes the major health policy provisions of the Act.
Continue Reading American Recovery and Reinvestment Act — Health Information Privacy/Incentives, Medicaid Funding & Other Health Provisions